NFSG
HUMA icon

Newbridge Financial Services Group’s Humacyte HUMA Stock Holding History

Newbridge Financial Services Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60
Closed -$36 – 1254
2026
Q1 		$36 Hold
60
– – ﹤0.01% 1168
2025
Q4 		$58 Hold
60
– – ﹤0.01% 1158
2025
Q3 		$104 Hold
60
– – ﹤0.01% 1258
2025
Q2 		$125 Hold
60
– – ﹤0.01% 1278
2025
Q1 		$102 Hold
60
– – ﹤0.01% 1011
2024
Q4 		$303 Buy
+60
New +$297 ﹤0.01% 1077

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newbridge Financial Services Group's HUMA Position: Q2 2026 in Review

Newbridge Financial Services Group sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 60 shares — an estimated $36 sold.

Newbridge Financial Services Group first reported a position in HUMA in Q4 2024 and held it in 6 quarters. The position peaked at $303 in Q4 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Newbridge Financial Services Group reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Newbridge Financial Services Group sold 60 Humacyte shares in Q2 2026, an estimated $36.
  • Newbridge Financial Services Group first reported a position in Humacyte in Q4 2024 and held it in 6 quarters.
  • Newbridge Financial Services Group's Humacyte position peaked at $303 in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.